Skip to content

XOMA Corporation XOMA Receipts Under Agreements Investing Activities

Receipts Under Agreements Investing Activities at other companies

Perrigo Company logo
Perrigo CompanyPRGO
$1.4M-17.6%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$0-100%
Marsh logo
MarshMRSH
$12M
Incyte logo
IncyteINCY
$0-100%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$107.75M+50.9%
Philip Morris International logo
Philip Morris InternationalPM
$29M

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept xoma:ReceiptsUnderAgreementsInvestingActivities.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's receipts under agreements investing activities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's receipts under agreements investing activities?
XOMA Corporation (XOMA) reported receipts under agreements investing activities of $235K in Q1 2026.
How has XOMA Corporation's receipts under agreements investing activities changed year-over-year?
XOMA Corporation's receipts under agreements investing activities decreased by 82.0% year-over-year, from $1.31M to $235K.
What is the long-term trend for XOMA Corporation's receipts under agreements investing activities?
Over 3 years (2022 to 2025), XOMA Corporation's receipts under agreements investing activities has grown at a 2.9% compound annual growth rate (CAGR), from $3.03M to $3.3M.
What does receipts under agreements investing activities mean?
Represents cash inflows received from royalty-bearing assets or contractual arrangements acquired by the company. These receipts reflect the monetization of underlying therapeutic candidates as they reach commercial or developmental milestones.